Cannabis Bioscience International Holdings, Inc. (CBIH)

Revenue by Product

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2010	May 31, 2009
Clinical Trials	213.87K
Clinical Trials Growth	-19.97%
Consulting Fees	28.64K
Consulting Fees Growth	243.71%
Merchandise	4.41K
Merchandise Growth	-80.22%
Seminar Fees	1.93K
Seminar Fees Growth	-88.29%

Revenue by Geography

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2010	May 31, 2009
United States and Latin America	248.84K
United States and Latin America Growth	-21.46%